Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
CNS Drugs|February 8, 2014
Neuroprotective properties of citicoline: facts, doubts and unresolved issuesPawel GriebJournal of Neuroscience Research|January 10, 2002
Pharmacodynamics of citicoline relevant to the treatment of glaucomaPawel Grieb, Robert RejdakFrontiers in Aging Neuroscience|April 20, 2016
Citicoline: A Food Beneficial for Patients Suffering from or Threated with GlaucomaPawel Grieb, Anselm Jünemann, Marek Rekas, et al.Current Research in Pharmacology and Drug Discovery|December 6, 2021
Hypoxia may be a determinative factor in COVID-19 progressionPawel Grieb, Maciej Swiatkiewicz, Katarzyna Prus, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 1, 2011
Magnetic resonance in studies of glaucomaMichal Fiedorowicz, Wojciech Dyda, Robert Rejdak, et al.AAPS Pharmscitech|November 20, 2010
In vivo assessment of parenteral formulations of oligo(3-hydroxybutyric Acid) conjugates with the model compound IbuprofenPawel Stasiak, Malgorzata Sznitowska, Carsten Ehrhardt, et al.Folia Neuropathologica|October 14, 2014
Age-dependent neuroprotection of retinal ganglion cells by tempol-C8 acyl ester in a rat NMDA toxicity modelMichal Fiedorowicz, Robert Rejdak, Frank Schuettauf, et al.Cell and Tissue Research|April 13, 2010
Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitroHanna Lawnicka, Magdalena Kowalewicz-Kulbat, Paulina Sicinska, et al.Neurological Research|December 17, 2009
Is the spinal cord motoneuron exclusively a target in ALS? Comparison between astroglial reactivity in a rat model of familial ALS and in human sporadic ALS casesJanina Rafalowska, Dorota Dziewulska, Roman Gadamski, et al.Klinika Oczna|March 7, 2013
[New drug VEGF Trap-Eye--Eylea--and its use in the treatment of age-related macular degeneration, central retinal vein occlusion, diabetic macular edema, and choroidal neovascularization secondary to pathologic myopia]Robert Rejdak, Małgorzata Szkaradek, Wesam Taslaq, et al.Pageof 4